Structural Heart Devices Market Scenario
The global structural heart devices market is predicted to demonstrate 10.4% CAGR during the forecast period (2018-2023) owing to the increasing frequency of structural heart diseases, asserts Market Research Future (MRFR). Structural heart disease is referred to the cardiac defects which are generally inherited by birth and are developed later in life, due to wear and tear from infection. The common structural heart diseases include ventricular septal defect, atrial septal defect, arterial/venous fistulae, paravalvular leak, congenital heart disease, and patent foramen oval. With advancements in the medical field, the open-heart surgical procedures have replaced with minimally invasive procedures like transcatheter mitral valve repair (TMVR) and transcatheter aortic valve replacement (TAVR).
Drivers and Constraints Impacting the Market
With the increasing prevalence of structural heart diseases, development of innovative repair devices like occluders and annuloplasty rings, technological advancements, and the growing demand for minimally invasive techniques, the global structural heart devices market is considered to propel during the assessment period. The increased focus of the key players on research and development activities of structural heart devices coupled with the upsurge in demand for long-lasting and quick procedures among the geriatric population are considered to offer lucrative opportunities for the players in the global market. Moreover, regulatory approvals of advanced and new structural heart devices, rising awareness about structural heart diseases, and favorable reimbursement scenario are likely to boost the market growth in the coming years.
On the flip side, high cost associated with the surgeries coupled with strict government mandates are some of the major concerns considered to dampen the global structural heart devices market growth during the appraisal period. Advanced products like sutureless heart valve cost higher than the earlier available products. The high price of sutureless devices will further limit the adoption of the equipment, thereby impeding the market growth during the forecast period.
Global Structural Heart Devices Market: Segmental Analysis
The global structural heart devices market has been segmented on the basis of indication, type, procedure, end-user, and region.
By mode of type, the global structural heart devices market has been segmented into occluders and delivery systems, heart valve devices, accessories, annuloplasty rings, and other devices. Among these, the heart valve devices are further sub-segmented into surgical heart valves and transcatheter heart valves. The surgical heart valves are sub-segmented into mechanical heart valves and tissue heart valves. Among these, the heart valve devices segment is considered to account for the largest market share owing to the increasing number of transcatheter aortic valve replacement procedures being performed across the world, growing number of regulatory approvals for heart valve devices, and durability and efficacy of these products.
By mode of indication, the global structural heart devices market has been segmented into cardiomyopathy, valvular heart disease, congenital heart defects, and others. Among these, the valvular heart disease has been further sub-segmented into stenosis and regurgitation.
By mode of procedure, the global structural heart devices market has been segmented into repair procedures and replacement procedures. Among these, the replacement procedures have been further sub-segmented into SAVR procedures and TAVR procedures. The repair procedures have been sub-segmented into annuloplasty, closure procedures, TMVR procedures and valvuloplasty. Among these, the replacement procedures segment is considered to hold the largest market share owing to the long-term durability of such procedures along with the widespread preference for transcatheter replacement.
By mode of end-users, the global structural heart devices market has been segmented into ambulatory surgery centers, hospitals, and others.
Structural Heart Devices Market Regional Insights
Geographically, the structural heart devices market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.
Among all the regions, the American region is considered to lead the global structural heart devices market. The increasing rate of surgeries due to high blood pressure, diabetes, and other factors contribute to the growth of the market. Moreover, growing healthcare awareness, medical tourism, technological advancements, and rising disposable income are likely to fuel the market growth in this region.
Europe is considered to hold the second largest position in the global market as structural heart devices market is most prevalent in Germany. Moreover, the increasing geriatric population, rising prevalence of obesity and diabetes are influencing the market growth in this region.
The Asia Pacific region is considered to be the fastest growing region owing to the increasing patient population, growing elderly population, and changing lifestyle. Such factors are considered to offer favorable backgrounds to the market growth.
Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385
Structural Heart Devices Industry Updates
December 26, 2018: Keystone Heart is enrolling patients in the U.S. for a trial of its TriGuard 3 product, hoping for FDA approval in the third quarter of 2019. The company also expects to win the CE Mark approval for the device.
Structural Heart Devices Market Competitive Dashboard
The prominent players operating the global structural heart devices market are ST. Jude Medical, JenaValve Technology Inc., Comed BV, Boston Scientific Corporation (US), LivaNova plc (UK), Cook Group Incorporated (US), Biometrics, Edwards Lifesciences Corporation (US), Abbott (US), W. L. Gore & Associates Inc. (US), Medtronic plc (Ireland), CardioKinetix, and Endologix Inc. (US).
We conduct an accurate and reliable COVID Test.
Our qualified phlebotomists trained for safe and hygienic sample collecting during Test for COVID 19.
We are the most trustworthy lab for COVID 19 testing in India.
Get your COVID-19 Test done with Metropolis Healthcare.
Get all the updates about Covid-19 in UAE on Call Doctor UAE.
During the Covid-19 pandemic, we are providing premium home healthcare throughout Dubai & Abu Dhabi.
Bangladesh has Taken the Decision to Postpone the Upcoming Sri Lanka tour to Bangladesh Because of the COVID-19 Pandemic.
For More Details Visit Stumpsandbails.com
The COVID-19 pandemic has changes the working of real estate sector and has led to the change in the way real estate marketing used to be done.
Severe Acute Respiratory Syndrome-Related Coronavirus 2(SARS-CoV2) or the COVID-19 virus has led to a global pandemic causing havoc all across.
The situation of the Covid-19 leaving the cricketing calendar ripped to shreds, and concerns are being asked this year about India's Tour to Australia.
